Template:Nucleic acid inhibitors: Difference between revisions
Content deleted Content added
added sulfaguanidine |
Innerstream (talk | contribs) No edit summary |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 5: | Line 5: | ||
| listclass = hlist |
| listclass = hlist |
||
| group1 = [[Antifolate]]s<br |
| group1 = [[Antifolate]]s<br/>(inhibit bacterial<br/>[[purine metabolism|purine metabolism]],<br/>thereby inhibiting<br/>DNA and RNA<br/>synthesis) |
||
| list1 = {{Navbox|child |
| list1 = {{Navbox|child |
||
| Line 14: | Line 14: | ||
** [[Iclaprim]]<sup>†</sup> |
** [[Iclaprim]]<sup>†</sup> |
||
** [[Ormetoprim]] |
** [[Ormetoprim]] |
||
** [[Pyrimethamine]]<sup>#</sup> |
|||
** [[Tetroxoprim]] |
** [[Tetroxoprim]] |
||
** [[Trimethoprim]]<sup>#</sup> |
** [[Trimethoprim]]<sup>#</sup> |
||
| Line 20: | Line 21: | ||
| list2 = {{Navbox|child |
| list2 = {{Navbox|child |
||
| group1 = [[Sulfonamide (medicine)#Short-acting|Short- |
| group1 = [[Sulfonamide (medicine)#Short-acting|Short-acting]] |
||
| list1 = |
| list1 = |
||
* [[Sulfisomidine|Sulfaisodimidine]] |
* [[Sulfisomidine|Sulfaisodimidine]] |
||
| Line 32: | Line 33: | ||
* [[Sulfathiourea]] |
* [[Sulfathiourea]] |
||
| group2 = [[Sulfonamide (medicine)#Intermediate-acting|Intermediate- |
| group2 = [[Sulfonamide (medicine)#Intermediate-acting|Intermediate-acting]] |
||
| list2 = |
| list2 = |
||
* [[Sulfamethoxazole]] |
* [[Sulfamethoxazole]] |
||
| Line 38: | Line 39: | ||
* [[Sulfamoxole]] |
* [[Sulfamoxole]] |
||
| group3 = [[Sulfonamide (medicine)#Long-acting|Long- |
| group3 = [[Sulfonamide (medicine)#Long-acting|Long-acting]] |
||
| list3 = |
| list3 = |
||
* [[Sulfadimethoxine]] |
* [[Sulfadimethoxine]] |
||
| Line 53: | Line 54: | ||
| group4 = Other/ungrouped |
| group4 = Other/ungrouped |
||
| list4 = |
| list4 = |
||
* [[Mafenide]] |
|||
* [[Sulfacetamide]] |
* [[Sulfacetamide]] |
||
* [[Sulfaclozine]] |
* [[Sulfaclozine]] |
||
| Line 66: | Line 68: | ||
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup> |
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup> |
||
* [[Sulfadimethoxine#with ormetoprim|Ormetoprim/sulfadimethoxine]] |
* [[Sulfadimethoxine#with ormetoprim|Ormetoprim/sulfadimethoxine]] |
||
* [[Pyrimethamine/dapsone]] |
|||
* [[Pyrimethamine/sulfadoxine]] |
|||
| Line 78: | Line 82: | ||
}} |
}} |
||
| group2 = [[ |
| group2 = [[Quinolone antibiotic|Quinolone]]s<br/>(inhibit bacterial<br/>[[Topoisomerase inhibitor|topoisomerase]]<br/>and/or [[DNA gyrase|DNA gyrase]],<br/>thereby inhibiting<br/>[[DNA replication]]) |
||
| list2 = {{Navbox|child |
| list2 = {{Navbox|child |
||
| group1 = [[Quinolone antibiotic#First generation|1st |
| group1 = [[Quinolone antibiotic#First generation|1st generation]] |
||
| list1 = |
| list1 = |
||
* [[Cinoxacin]]<sup>‡</sup> |
* [[Cinoxacin]]<sup>‡</sup> |
||
| Line 91: | Line 95: | ||
* [[Rosoxacin]]<sup>‡</sup> |
* [[Rosoxacin]]<sup>‡</sup> |
||
| group2 = [[Quinolone antibiotic| |
| group2 = [[Quinolone antibiotic|Fluoroquinolones]] |
||
| list2 = {{Navbox|child |
| list2 = {{Navbox|child |
||
| group1 = [[Quinolone antibiotic#Second generation|2nd |
| group1 = [[Quinolone antibiotic#Second generation|2nd generation]] |
||
| list1 = |
| list1 = |
||
* [[Ciprofloxacin]]<sup>#</sup> |
* [[Ciprofloxacin]]<sup>#</sup> |
||
| Line 101: | Line 105: | ||
* [[Fleroxacin]]<sup>‡</sup> |
* [[Fleroxacin]]<sup>‡</sup> |
||
* [[Lomefloxacin]]<sup>‡</sup> |
* [[Lomefloxacin]]<sup>‡</sup> |
||
* [[Nadifloxacin]]<sup>‡</sup> |
* [[Nadifloxacin]]<sup>‡</sup>/[[Levonadifloxacin]]/[[Alalevonadifloxacin]] |
||
* [[Norfloxacin]]<sup>‡</sup> |
* [[Norfloxacin]]<sup>‡</sup> |
||
* [[Pefloxacin]]<sup>‡</sup> |
* [[Pefloxacin]]<sup>‡</sup> |
||
* [[Rufloxacin]]<sup>‡</sup> |
* [[Rufloxacin]]<sup>‡</sup> |
||
| group2 = [[Quinolone antibiotic#Third generation|3rd |
| group2 = [[Quinolone antibiotic#Third generation|3rd generation]] |
||
| list2 = |
| list2 = |
||
* [[Levofloxacin]]<sup>#</sup> |
* [[Levofloxacin]]<sup>#</sup> |
||
| Line 116: | Line 120: | ||
* [[Tosufloxacin]]<sup>‡</sup> |
* [[Tosufloxacin]]<sup>‡</sup> |
||
| group3 = [[Quinolone antibiotic#Fourth generation|4th |
| group3 = [[Quinolone antibiotic#Fourth generation|4th generation]] |
||
| list3 = |
| list3 = |
||
* [[Besifloxacin]] |
* [[Besifloxacin]] |
||
| Line 131: | Line 135: | ||
| group4 = [[Quinolone antibiotic#Veterinary use| |
| group4 = [[Quinolone antibiotic#Veterinary use|Veterinary]] |
||
| list4 = |
| list4 = |
||
* [[Danofloxacin]] |
* [[Danofloxacin]] |
||
| Line 146: | Line 150: | ||
| list3 = |
| list3 = |
||
* [[Nemonoxacin]] |
* [[Nemonoxacin]] |
||
* [[Ozenoxacin]] |
|||
| group4 = Related ([[DNA gyrase|DG]]) |
| group4 = Related ([[DNA gyrase|DG]]) |
||
| Line 155: | Line 160: | ||
| list3 = {{Navbox|child |
| list3 = {{Navbox|child |
||
| group1 = [[Nitroimidazole |
| group1 = [[Nitroimidazole]] derivatives |
||
| list1 = |
| list1 = |
||
* [[Metronidazole]]<sup>#</sup> |
* [[Metronidazole]]<sup>#</sup> |
||
Latest revision as of 17:15, 4 May 2024
This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state= parameter may be used:
{{Nucleic acid inhibitors|state=collapsed}}will show the template collapsed, i.e. hidden apart from its title bar.{{Nucleic acid inhibitors|state=expanded}}will show the template expanded, i.e. fully visible.